|
|
US 7,611,904 B2 |
|
| Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| Daniel E. Afar, Pacific Palisades, Calif. (US); Rene S. Hubert, Los Angeles, Calif. (US); Kahan Leong, Playa Del Rey, Calif. (US); Arthur B. Raitano, Los Angeles, Calif. (US); Douglas C. Saffran, Los Angeles, Calif. (US); and Stephen Chappell Mitchell, Santa Monica, Calif. (US) |
| Assigned to Agensys, Inc., Santa Monica, Calif. (US) |
| Filed on Oct. 12, 2006, as Appl. No. 11/580,538. |
| Application 10/750262 is a division of application No. 10/011095, filed on Dec. 06, 2001, granted, now 7,053,186, filed on May 30, 2006. |
| Application 10/011095 is a division of application No. 09/323873, filed on Jun. 01, 1999, granted, now 6,329,503, filed on Dec. 11, 2001. |
| Application 11/580538 is a continuation of application No. 10/750262, filed on Dec. 31, 2003, granted, now 7,166,714. |
| Claims priority of provisional application 60/091183, filed on Jun. 30, 1998. |
| Claims priority of provisional application 60/087520, filed on Jun. 01, 1998. |
| Claims priority of provisional application 60/317840, filed on Sep. 06, 2001. |
| Claims priority of provisional application 60/370387, filed on Apr. 05, 2002. |
| Prior Publication US 2007/0104720 A1, May 10, 2007 |
| Int. Cl. G01N 33/53 (2006.01)
|